Protective role of Ashwagandha leaf extract and its component withanone on scopolamine-induced changes in the brain and brain-derived cells.

<h4>Background</h4>Scopolamine is a well-known cholinergic antagonist that causes amnesia in human and animal models. Scopolamine-induced amnesia in rodent models has been widely used to understand the molecular, biochemical, behavioral changes, and to delineate therapeutic targets of me...

Descripción completa

Guardado en:
Detalles Bibliográficos
Autores principales: Arpita Konar, Navjot Shah, Rumani Singh, Nishant Saxena, Sunil C Kaul, Renu Wadhwa, Mahendra K Thakur
Formato: article
Lenguaje:EN
Publicado: Public Library of Science (PLoS) 2011
Materias:
R
Q
Acceso en línea:https://doaj.org/article/40873a4c2d464626ae454b1bff8f0909
Etiquetas: Agregar Etiqueta
Sin Etiquetas, Sea el primero en etiquetar este registro!
id oai:doaj.org-article:40873a4c2d464626ae454b1bff8f0909
record_format dspace
spelling oai:doaj.org-article:40873a4c2d464626ae454b1bff8f09092021-11-18T07:34:30ZProtective role of Ashwagandha leaf extract and its component withanone on scopolamine-induced changes in the brain and brain-derived cells.1932-620310.1371/journal.pone.0027265https://doaj.org/article/40873a4c2d464626ae454b1bff8f09092011-01-01T00:00:00Zhttps://www.ncbi.nlm.nih.gov/pmc/articles/pmid/22096544/pdf/?tool=EBIhttps://doaj.org/toc/1932-6203<h4>Background</h4>Scopolamine is a well-known cholinergic antagonist that causes amnesia in human and animal models. Scopolamine-induced amnesia in rodent models has been widely used to understand the molecular, biochemical, behavioral changes, and to delineate therapeutic targets of memory impairment. Although this has been linked to the decrease in central cholinergic neuronal activity following the blockade of muscarinic receptors, the underlying molecular and cellular mechanism(s) particularly the effect on neuroplasticity remains elusive. In the present study, we have investigated (i) the effects of scopolamine on the molecules involved in neuronal and glial plasticity both in vivo and in vitro and (ii) their recovery by alcoholic extract of Ashwagandha leaves (i-Extract).<h4>Methodology/principal findings</h4>As a drug model, scopolamine hydrobromide was administered intraperitoneally to mice and its effect on the brain function was determined by molecular analyses. The results showed that the scopolamine caused downregulation of the expression of BDNF and GFAP in dose and time dependent manner, and these effects were markedly attenuated in response to i-Extract treatment. Similar to our observations in animal model system, we found that the scopolamine induced cytotoxicity in IMR32 neuronal and C6 glioma cells. It was associated with downregulation of neuronal cell markers NF-H, MAP2, PSD-95, GAP-43 and glial cell marker GFAP and with upregulation of DNA damage--γH2AX and oxidative stress--ROS markers. Furthermore, these molecules showed recovery when cells were treated with i-Extract or its purified component, withanone.<h4>Conclusion</h4>Our study suggested that besides cholinergic blockade, scopolamine-induced memory loss may be associated with oxidative stress and Ashwagandha i-Extract, and withanone may serve as potential preventive and therapeutic agents for neurodegenerative disorders and hence warrant further molecular analyses.Arpita KonarNavjot ShahRumani SinghNishant SaxenaSunil C KaulRenu WadhwaMahendra K ThakurPublic Library of Science (PLoS)articleMedicineRScienceQENPLoS ONE, Vol 6, Iss 11, p e27265 (2011)
institution DOAJ
collection DOAJ
language EN
topic Medicine
R
Science
Q
spellingShingle Medicine
R
Science
Q
Arpita Konar
Navjot Shah
Rumani Singh
Nishant Saxena
Sunil C Kaul
Renu Wadhwa
Mahendra K Thakur
Protective role of Ashwagandha leaf extract and its component withanone on scopolamine-induced changes in the brain and brain-derived cells.
description <h4>Background</h4>Scopolamine is a well-known cholinergic antagonist that causes amnesia in human and animal models. Scopolamine-induced amnesia in rodent models has been widely used to understand the molecular, biochemical, behavioral changes, and to delineate therapeutic targets of memory impairment. Although this has been linked to the decrease in central cholinergic neuronal activity following the blockade of muscarinic receptors, the underlying molecular and cellular mechanism(s) particularly the effect on neuroplasticity remains elusive. In the present study, we have investigated (i) the effects of scopolamine on the molecules involved in neuronal and glial plasticity both in vivo and in vitro and (ii) their recovery by alcoholic extract of Ashwagandha leaves (i-Extract).<h4>Methodology/principal findings</h4>As a drug model, scopolamine hydrobromide was administered intraperitoneally to mice and its effect on the brain function was determined by molecular analyses. The results showed that the scopolamine caused downregulation of the expression of BDNF and GFAP in dose and time dependent manner, and these effects were markedly attenuated in response to i-Extract treatment. Similar to our observations in animal model system, we found that the scopolamine induced cytotoxicity in IMR32 neuronal and C6 glioma cells. It was associated with downregulation of neuronal cell markers NF-H, MAP2, PSD-95, GAP-43 and glial cell marker GFAP and with upregulation of DNA damage--γH2AX and oxidative stress--ROS markers. Furthermore, these molecules showed recovery when cells were treated with i-Extract or its purified component, withanone.<h4>Conclusion</h4>Our study suggested that besides cholinergic blockade, scopolamine-induced memory loss may be associated with oxidative stress and Ashwagandha i-Extract, and withanone may serve as potential preventive and therapeutic agents for neurodegenerative disorders and hence warrant further molecular analyses.
format article
author Arpita Konar
Navjot Shah
Rumani Singh
Nishant Saxena
Sunil C Kaul
Renu Wadhwa
Mahendra K Thakur
author_facet Arpita Konar
Navjot Shah
Rumani Singh
Nishant Saxena
Sunil C Kaul
Renu Wadhwa
Mahendra K Thakur
author_sort Arpita Konar
title Protective role of Ashwagandha leaf extract and its component withanone on scopolamine-induced changes in the brain and brain-derived cells.
title_short Protective role of Ashwagandha leaf extract and its component withanone on scopolamine-induced changes in the brain and brain-derived cells.
title_full Protective role of Ashwagandha leaf extract and its component withanone on scopolamine-induced changes in the brain and brain-derived cells.
title_fullStr Protective role of Ashwagandha leaf extract and its component withanone on scopolamine-induced changes in the brain and brain-derived cells.
title_full_unstemmed Protective role of Ashwagandha leaf extract and its component withanone on scopolamine-induced changes in the brain and brain-derived cells.
title_sort protective role of ashwagandha leaf extract and its component withanone on scopolamine-induced changes in the brain and brain-derived cells.
publisher Public Library of Science (PLoS)
publishDate 2011
url https://doaj.org/article/40873a4c2d464626ae454b1bff8f0909
work_keys_str_mv AT arpitakonar protectiveroleofashwagandhaleafextractanditscomponentwithanoneonscopolamineinducedchangesinthebrainandbrainderivedcells
AT navjotshah protectiveroleofashwagandhaleafextractanditscomponentwithanoneonscopolamineinducedchangesinthebrainandbrainderivedcells
AT rumanisingh protectiveroleofashwagandhaleafextractanditscomponentwithanoneonscopolamineinducedchangesinthebrainandbrainderivedcells
AT nishantsaxena protectiveroleofashwagandhaleafextractanditscomponentwithanoneonscopolamineinducedchangesinthebrainandbrainderivedcells
AT sunilckaul protectiveroleofashwagandhaleafextractanditscomponentwithanoneonscopolamineinducedchangesinthebrainandbrainderivedcells
AT renuwadhwa protectiveroleofashwagandhaleafextractanditscomponentwithanoneonscopolamineinducedchangesinthebrainandbrainderivedcells
AT mahendrakthakur protectiveroleofashwagandhaleafextractanditscomponentwithanoneonscopolamineinducedchangesinthebrainandbrainderivedcells
_version_ 1718423280527867904